Wonder molecule mRNA, 2

The World's Most Famous Neurosurgeon in Conversation: «Empathy Is Important, But Not The Essential Quality For a Doctor»

photo of author of the article

He is the most renowned student of Nobel laureate Katalin Karikó: David Langer, neurosurgeon and Netflix star, reveals how the scientist shaped him for life – and the challenges he sees in medicine today.

Everyone in the U.S. connected to medicine knows him: Lenox Hill neurosurgeon David Langer.

Everyone in the U.S. connected to medicine knows him: Lenox Hill neurosurgeon David Langer.

zvg

Continuation from part 1

When the future Nobel laureate Katalin Karikó first crossed paths with the son of a prominent cardiology professor, sparks flew. After David Langer botched an experiment, Karikó – then an unknown researcher without a leadership role – scolded the young man. Unlike other students, Langer didn’t take it personally. Instead, he redoubled his efforts and threw himself into working with the demanding Karikó – a decision that later propelled him to professional heights.

After leaving the lab bench, Langer trained as a neurosurgeon and eventually became head of neurosurgery at New York’s Lenox Hill Hospital. Under his leadership, the hospital rose to become one of the nation’s leading centers. Streaming giant Netflix went on to produce two series about Langer’s career – Lenox Hill and Emergency NYC. In this interview, David Langer talks about his intense years with Katalin Karikó, the potential of mRNA, and the advice he gives young people embarking on their careers.

What role did «Katie» play in your career? What did you learn from her?

I met Katie in a cardiology lab in 1989/90. I kept coming back during medical school. As a resident, I spent extended periods doing research there. It was only in my final year of training that I shifted toward neurosurgery. She was already an impressive figure from whom I learned a great deal.

What exactly did you learn from her?

How important it is to do the right thing, even in difficult situations. And also that one should always speak truth to power. I saw firsthand the trouble her stance caused her. Yet that philosophy shaped me – in small matters and in large. Katie was remarkably efficient. She’d only fill a beaker one-third full to avoid wasting water. Above all, she was radically clean in her methodology: data comes first, even when the results don’t fit. It’s never «the experiment is to blame,» but always «what does the result tell us?» She was methodical, deliberate, and would read 30 papers a night, while I reacted more emotionally. Clinically, that taught me to verify things myself, not to follow the money, but to pursue what is meaningful.

Back then you were researching mRNA applications in neurosurgery, for example as a drug for stroke. You left that field. Looking back, do you see potential for mRNA in neurosurgery?

If anything, as a therapeutic: for tumors, vascular disease, or neurodegenerative disorders. mRNA can selectively increase protein levels in tissue. If we identify the right target mechanism and vector, it will have a role. But surgery itself remains device-based.

When did you know you wanted to become a neurosurgeon?

As a teenager I thought about it briefly, but neurosurgery was grim back then: no MRIs, primitive CTs, poor outcomes. My father was a cardiologist, so I first leaned toward cardiology. Then, just before I began my studies, he suffered a stroke. That made me more comfortable with neurological patients. In medical school I became fascinated by neuroanatomy, especially cranial nerves and the skull base. My first rotation was internal medicine – but I missed operating. I also saw how unhealthy the culture was: many physicians divorced multiple times, keeping affairs on the side. Then, in the ER, I witnessed a ventriculostomy: drill, CSF gushing out – and I knew, that’s what I want to do.

Is there an operation you’ll never forget?

Early in my career, I operated on a young HIV-positive mother with a massive brain malformation. The surgery lasted from 8 a.m. until 11 p.m., with endless bleeding. But she recovered well, and we stayed in touch for a long time. Another was a nearly blind patient with a large skull-base tumor. Three days after surgery, her vision returned – incredible. And I’ll never forget when the head of anesthesia at my hospital suffered a ruptured aneurysm in his office. The entire institution watched us – and he survived.

You’ve been operating for decades. Has your view of the brain changed?

Neurosurgeons are rarely neuroscientists. We know where to place the scalpel and where not to; we distinguish good from bad vessels and regions. Earlier, I was more reverent. Now I’m more cautious. Bad complications affect patients longer than successes. That makes you more conservative: I don’t want to harm people with my operations.

Article series

Miracle Molecule mRNA – Katalin Karikó’s Legacy

No other method holds as much potential to revolutionize medicine as mRNA technology. The mRNA research, significantly shaped by the Hungarian-American biochemist Katalin Karikó, has doctors dreaming of curing infectious diseases, genetic disorders, and cancer within the coming years. In this series, we highlight projects by leading researchers who, building on Karikó’s work, are introducing mRNA technology into various fields of medicine.

What qualities do neurosurgeons need today?

The field has changed dramatically: far fewer open surgeries, far more minimally invasive procedures, robotics, and ultrasound. More elegance and finesse, fewer «militaristic» mega-operations. You no longer need extraordinary manual dexterity; planning, devices, and algorithms often matter more. But training is long and grueling. Anyone choosing it must truly love the work.

How important is empathy in medicine?

It isn’t essential to the outcome. You don’t get paid for empathy; in doubt, patients prefer expertise over boundless compassion. If forced to choose, I’d pick technical excellence – to avoid harming anyone. But empathy makes the profession human and interesting. I want both.

David Langer also teaches young doctors to become neurosurgeons.

David Langer also teaches young doctors to become neurosurgeons.

Pic: Youtube

You mentioned major changes in your field. What does a typical day look like for you?

I spend about 30–40 percent of my time in the OR. The rest is team leadership, communication, and administration. I’d love to operate more, but training younger colleagues and having time to think are also part of my role.

You’re the star of two Netflix documentaries. How has that attention changed your life?

The «fame» was less significant than expected. Recognition is pleasant, but not essential. More valuable were encounters with young people and the chance to discuss values: wisdom, justice, courage, and moderation. Fame doesn’t make you happy; it’s like chewing gum – sweet for a moment, then gone.

What do you do for your mental health?

I meditate daily and practice yoga 4–5 times a week for about an hour. It made me more present, less reactive. After a skiing accident that left me temporarily paralyzed, these activities became more important. I also love skiing and fishing, though I don’t do them often enough.

Let’s talk about AI, which your hospital already uses in many areas. Do you believe it will prevail?

Absolutely. It will bring greater change than almost anything before. AI will improve communication, decisions, safety, efficiency, and access to answers, especially in cognitive tasks. Surgeons will still be needed, but training will change. I also expect AI to relieve us of much administrative burden.

What are you working on with your own AI company?

On the patient experience. We’re developing AI that records patient conversations, generates doctor’s letters and notes. With our AI we can also provide patients with personalized summaries of their records, helping them better understand medicine. Generative avatars can answer many general questions.

Looking back, is there anything you’d do differently?

Perhaps I wouldn’t have left the University of Pennsylvania. I completely underestimated my relationship and work with Katie. Had I stayed, my life would have been entirely different. We might even have achieved something truly groundbreaking together in research. But I don’t regret moving into hospital work. I saved many lives and had the Netflix experience. Still, I miss working with Katie, because she is a historic figure.

Finally, what advice would you give young scientists in a similar position to yours back then?

Don’t focus too much on the end result. Love what you do – that’s most important. But it’s also vital to find good mentors and supportive environments. Science is a wonderful field, but the people you work with make all the difference. Katie provided exactly that environment for me. That’s why I chose it then – not for money or fame.

Katalin Karikó never held a formal leadership role during her years at the University of Pennsylvania, and officially had no students. But after her move to a neurosurgery research division in 1997, she met another man who would play a decisive role in continuing her work after her dismissal at age 57…

Part 3 of the series can be found here .

Note

* This article series has been nominated for the Prix Média Newcomer 2025 and was supported by the Swiss Academy of Sciences.

Mehr zum Thema
Wonder molecule mRNA, 1

How a Butcher's Daughter Saved Millions of Lives — and Is Now Helping to Cure Countless Diseases

09.09.2025
Wonder molecule mRNA, 2

The World's Most Famous Neurosurgeon in Conversation: «Empathy Is Important, But Not The Essential Quality For a Doctor»

09.09.2025
David Langer also teaches young doctors to become neurosurgeons.
Wonder molecule mRNA, 3

«The mRNA technology still holds enormous potential», says the man who played a key role in the development of the COVID vaccine

09.09.2025
Professor Norbert Pardi also collaborates with Swiss researchers.
Wonder molecule mRNA, 4

A Nobel Prize Winner at BioNTech: Why Katalin Karikó Remembers Two Collegues So Fondly

09.09.2025
The mRNA pioneer with BioNTech researcher Jason Keller at a conference.
Wonder molecule mRNA, 5

How Swiss Funding Is Helping Top Scientist Katalin Karikó Boost mRNA Research in Europe

09.09.2025
Professor Attila Gácser is working to turn Hungary’s University of Szeged into a leading center for mRNA research.

Für Sie empfohlen

Melden Sie sich an und erhalten Sie hier Ihre individuellen Leseempfehlungen.

Aktuelle Nachrichten